← FDA DRUG APPROVALS

FDA ANDA · ANDA075572

BUSPIRONE HYDROCHLORIDE

Sponsor: NESHER PHARMS

APPLICATION
ANDA075572
TYPE
ANDA
ORIGINAL APPROVAL
2002-02-27
LATEST ACTION
2002-02-27
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

BUSPIRONE HYDROCHLORIDEDiscontinued
BUSPIRONE HYDROCHLORIDE 15MG · TABLET · ORAL
BUSPIRONE HYDROCHLORIDEDiscontinued
BUSPIRONE HYDROCHLORIDE 5MG · TABLET · ORAL
BUSPIRONE HYDROCHLORIDEDiscontinued
BUSPIRONE HYDROCHLORIDE 10MG · TABLET · ORAL

Approval history

2002-02-27Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →